{"@context":["https://w3id.org/fdo/context/v1",{"schema":"https://schema.org/","prov":"http://www.w3.org/ns/prov#","fdo":"https://w3id.org/fdo/vocabulary/"}],"@id":"https://fdo.portal.mardi4nfdi.de/fdo/Q378944","@type":"DigitalObject","kernel":{"@id":"https://fdo.portal.mardi4nfdi.de/fdo/Q378944","digitalObjectType":"https://schema.org/ScholarlyArticle","primaryIdentifier":"mardi:Q378944","kernelVersion":"v1","immutable":true,"modified":"2026-01-20T10:30:18Z"},"profile":{"@context":"https://schema.org","@type":"ScholarlyArticle","@id":"https://portal.mardi4nfdi.de/entity/Q378944","name":"Modeling prostate cancer response to continuous versus intermittent androgen ablation therapy","headline":"Modeling prostate cancer response to continuous versus intermittent androgen ablation therapy","description":"scientific article; zbMATH DE number 6226175","url":"https://portal.mardi4nfdi.de/entity/Q378944","datePublished":"2013-11-12","author":[{"@id":"https://portal.mardi4nfdi.de/entity/Q356924"},{"@id":"https://portal.mardi4nfdi.de/entity/Q182273"}],"publisher":[{"@id":"https://portal.mardi4nfdi.de/entity/Q187082"}],"identifier":{"@type":"PropertyValue","propertyID":"doi","value":"10.3934/DCDSB.2013.18.945","url":"https://doi.org/10.3934/DCDSB.2013.18.945"},"sameAs":["https://doi.org/10.3934/DCDSB.2013.18.945"]},"provenance":{"prov:generatedAtTime":"2026-01-20T10:30:18Z","prov:wasAttributedTo":"MaRDI Knowledge Graph"}}